Gender medicine – deriving novelty from treating women?
26 Jun 2019
When you hear the term “gender medicine”, what comes to mind? For many people, the term is associated with reproductive health issues, such as pregnancy,.
Singapore biotech start-ups: the importance of patent protection
21 Jun 2019
Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is largely thanks to an initiative launched in 2000 aimed at.
Tips from the top: inspiring women in technology
19 Jun 2019
You may be surprised to hear that only 17% of those working in Technology in the UK are female. With this figure in mind, it’s important that others.
EU approves first gene therapy for patients with a mild form of β-Thalassemia
04 Jun 2019
Exciting news in the personalised medicine space – the EU has just approved the first gene therapy for patients with a mild form of β-Thalassemia. .
Precision therapeutics for the precision medicine era
17 May 2019
In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.
Personalised medicine: patient stratification
29 Apr 2019
While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.
Pioneers of precision medicine
15 Apr 2019
Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is leading.
Building an effective drug franchise: A Transatlantic perspective - April 23, Boston, MA
02 Apr 2019
It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your discoveries . In.
Dosage regimen patents: bruised but not beaten
28 Mar 2019
Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.
Playing for time: strategies that can help extend a drug's patent life
25 Mar 2019
Can the EPO hold oral proceedings in Haar without infringing a party’s right to be heard? A new referral to the Enlarged Board raises this question.
06 Mar 2019
The right to be heard under Article 113(1) EPC requires that parties involved in proceedings before the EPO have the right to present their arguments at.
Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences
27 Feb 2019
We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.
Is your interest legitimate? New referral to the EBOA on double patenting
22 Feb 2019
EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal. The answers may force.
Plant related inventions: clarity at last?
06 Feb 2019
As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial prohibition at the EPO against the grant of patents for.
Fighting cancer with CAR-T therapies
04 Feb 2019
Commercialising genomic research in the US: tips for obtaining patent protection
30 Jan 2019
The field of genomics has seen incredible advances over the past few decades. Technological developments coupled with decreasing costs have fuelled this.
China - a key player in the global precision medicine race
30 Jan 2019
With a growing economy, and a large, ageing population, China is attracting attention from global pharmaceutical and biotechnology companies. China’s home.
Eight key themes from the J.P. Morgan Healthcare Conference
14 Jan 2019
I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers attending the 37th Annual J.P. Morgan Healthcare Conference.
Precision medicine: ethics, regulation and patent law
13 Dec 2018
New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with greater accuracy than ever before. Indeed, due to the.
Plant related inventions: the saga continues
10 Dec 2018
We may be approaching the end of the year, but the saga of patents for plant related inventions at the EPO continues to develop. The Administrative.